Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcopenia × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18 Thoracic 4 Lymphoid 4 Genitourinary 3 Head & Neck 2 Gynecologic 2 Breast 2 Plasma cell 1 Other hematologic neoplasm 1 Other 1 Dermatologic 1

Conditions

Multiple Myeloma 290 Lymphoma 77 Leukemia 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 55 Lymphoma, Non-Hodgkin 54 Hodgkin Disease 53 Leukemia, Lymphocytic, Chronic, B-Cell 52 Neoplasms, Plasma Cell 51 Leukemia, Myeloid, Acute 44 Lymphoma, Mantle-Cell 42 Myeloproliferative Disorders 39 Myelodysplastic Syndromes 39 Lymphoma, Follicular 39 Lymphoma, Large B-Cell, Diffuse 38 Neoplasms 36 Burkitt Lymphoma 36 Primary Myelofibrosis 35 Lymphoma, B-Cell, Marginal Zone 35 Lymphoma, Large-Cell, Immunoblastic 34 Lymphoma, T-Cell, Cutaneous 31 Leukemia, Myeloid, Accelerated Phase 31 Sezary Syndrome 30 Mycosis Fungoides 30 Leukemia, Myeloid, Chronic-Phase 30 Hematologic Neoplasms 29 Blast Crisis 29 Breast Neoplasms 28 Leukemia, Hairy Cell 27 Congenital Abnormalities 27 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04320420 2021-10-08

APA²

Weprom

Phase NA Unknown

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡